Please try another search
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. It provides liquid and lyophilized vials, pre-filled syringes, 3-pc ophthalmic droppers, pre-mix bags, dry and liquid syrups-bottles, tables, soft gels, capsules, suppositories, liquid and emulsion injectables in ampoules and vials, topicals, and sachets. The company was incorporated in 1990 and is headquartered in Chennai, India.
Name | Age | Since | Title |
---|---|---|---|
Sridhar Ganesan | 66 | 2014 | MD & Whole Time Director |
Damodaran Sathyanarayanan | 63 | 2016 | Non-Executive Independent Director |
R. Nagendran | 71 | 2022 | Non-Executive Independent Director |
Paarthipan Chingelput Chellappan | 71 | 1990 | Non-Executive Non-Independent Chairman |
Chanderkanta K. Gariyali | 75 | 2020 | Non-Executive Independent Director |
S. Deenadhayaln | 71 | 2022 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review